Skip to main content

Q&A: Protecting Patient Safety in Drug Trials (NPR)

To learn more about data safety monitoring boards and their role in protecting patients who participate in drug studies, NPR turned to statistician David DeMets. He’s the chairman of the Department of Biostatistics and Medical Informatics at the University of Wisconsin, and the author of several books on the subject, including Data Monitoring in Clinical Trials: A Case Studies Approach (Springer 2005).